Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

Data as of Jan 23
 +0.028 / +2.98%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues323.0K15.3M1.8M873.0K
Operating ExpensesGross Income----------
Total Operating Expenses16.4M17.3M14.1M13.6M
Non-Operating ExpensesOperating Income-16.1M-2.0M-12.3M-12.7M
Extraordinary Charge-4.0K-3.9M-5.2M-1.4M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.7M-6.5M-18.0M-14.4M
Net Income-16.7M-6.5M-18.0M-14.4M
Shares To Calculate EPSShares To Calculate EPS51.5M51.6M51.7M51.8M
Shares To Calculate EPS Diluted51.5M51.6M51.7M51.8M
Earnings Per ShareEPS-$0.32-$0.12-$0.35-$0.28
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.